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. The aim of this study was to determine if the brain uptake of 4-2 -methoxyphenyl -1-2 -N-2 -pyridinyl -pw 18 x x Žw 18 x . F fluorobenzamido ethylpiperazine F MPPF , a radioligand for the imaging of 5-HT receptors, is influenced by the action of .Ž . NAN-190 2.5 mgrkg i.v. . After 60 min, the animals were sacrificed and 13 areas of the brain were dissected for ex vivo gamma counting. The regional distribution of radioactivity was also assessed in brain slices using a storage phosphor system. Modulation of Ž . w 18 x P-glycoprotein was achieved by injection of cyclosporin A 50 mgrkg 30 min prior to injection of F MPPF.
The distribution of 18 F-derived radioactivity corresponded to regional 5-HT receptor density as known from autoradiography.
1A
w 18 x Modulation of P-glycoprotein with cyclosporin A caused a 5-to 10-fold increase in the uptake of F MPPF. Tissuercerebellum ratios in the brain correlated with receptor densities determined by in vitro autoradiography. Measurements of plasma radioactivity showed that the w 18 x Ž increased brain uptake of F MPPF is partially due to a rise in ligand delivery after treatment with cyclosporin A area under the curve, . Ž . AUC, increased by a factor of 1.8 . Biodistribution experiments in wild type and mdr1a yry knockout mice confirmed that w 18 x F MPPF is a substrate for P-glycoprotein. q 2000 Elsevier Science B.V. All rights reserved. w 18 x x 2 -N-2 -pyridinyl -p -F fluorobenzamido ethylpiperaŽw 18 x . zine F MPPF in the brain corresponds to 5-HT 1A Ž receptor localization Kung et al., 1996; Shiue et al., 1997;  . Le Bars et al., 1998; Ginovart et al., 2000 . Recently, our w 18 x Ž group presented the first human data for F MPPF Pas-. schier et al., 1999 Pas-. schier et al., , 2000a . Again, the radioactivity distribution in human CNS was in good agreement with known receptor localization and with previous PET studies, which w 11 x Ž employed carbonyl-C WAY 100635 Farde et al., 1998; . Gunn et al., 1998; Ito et al., 1999 It is known that P-glycoprotein, an ATP-driven transmembrane efflux pump, which is present with high density in brain endothelium, has a high affinity for lipophilic molecules of moderate weight and size that contain cationic Ž centers and planar aromatic domains Abbott and Romero, 1996; Dellinger et al., 1992; Pawagi et al., 1994; Pearce et al., 1990; Schinkel et al., 1996; Van Asperen et al., 1996 . Active transport back into the blood could result in w 18 x a lower brain penetration of F MPPF than might be expected from its lipophilicity. The efflux action of P-Ž glycoprotein can be inhibited by so-called modulators e.g.
. Ž cyclosporin A, verapamil, and PSC833 Begley, 1992; 0014-2999r00r$ -see front matter q 2000 Elsevier Science B.V. All rights reserved.
Ž . PII: S 0 0 1 4 -2 9 9 9 0 0 0 0 7 5 2 -4 ( )Scheme 1. Characteristics of MPPF and WAY 100635. Hendrikse et al., 1998; Hughes et al., 1998; Schinkel et al., . 1995; Van Asperen et al., 1996 . These compounds reduce P-glycoprotein functionality and thus prevent a radioligand from being expelled from the endothelial membrane back into the blood.
In rodents, two P-glycoproteins are present encoded by the mdr1a and mdr1b genes. Brain P-glycoprotein is Ž expressed by the mdr1a gene Borst and . Schinkel et al., 1995 Van Asperen et al., 1996 . The generation of mice with homozygously disrupted mdr1a w Ž . x genes mdr1a yry knockout mice has made it possible to test if the brain uptake of a drug is affected by the Ž action of P-glycoprotein Schinkel et al., 1995 Schinkel et al., , 1996 Van . Asperen et al., 1996 . If uptake of the radiopharmaceutical in the brain is indeed limited by the action of P-glycoprotein, inhibition of this pump by a modulator could result in improved counting statistics within the CNS. A positive result will demonstrate the importance of taking the action of Pglycoprotein into account during the development of radioligands for CNS receptors and for 5-HT receptor antag-1A onists in particular.
The aim of the present study was to investigate if the introduction of the extra aromatic ring in MPPF results in a decreased brain uptake due to the efflux action of P-glycoprotein. To that purpose, biodistribution experiments were performed in rats with modulated P-glyco-Ž . protein functionality and in mdr1a yry knockout mice. 
Materials and methods

All
Ž . ethylpiperazine 7 mg in DMF 0.7 ml , was added and the reaction mixture was heated to 1408C for 25 min. The Ž . reaction was quenched with water 4 ml and the mixture was passed through a Supelclean LC18 cartridge. The Ž . cartridge was washed with water 2 ml , 18% EtOH in Ž . Ž . water 4 ml and eluted with a mixture of methanol 1 ml Ž . and THF 0.33 ml , into a vial containing 1-ml water. . pH s 7.3 , 41:14:45; 3.0 mlrmin . The fraction containing w 18 x Ž F MPPF t s 30-35 min, U.V. 254 nm, S.A.) 110 R . TBqrmmol was collected, and the product was formu-Ž lated according to a modified literature procedure Lemaire . w 18 x et al., 1995 . The fraction containing F MPPF was diluted in 100-ml distilled water. Methanol and THF were removed by passing the mixture over a C18 SepPak light cartridge, followed by rinsing of the cartridge with 2 = 8 w 18 x ml of 0.9% saline solution.
F MPPF was eluted and formulated by passing 0.8 ml ethanol through the car-Ž . tridge, followed by 8 ml phosphate buffer pH s 7. 4-7.6 . Ž After filtration through a 0.22-mm sterile filter Millex, . GP , the product was ready for injection. Quality control Ž using reverse phase HPLC WATERS NovaPak: 150 = 3.6 Ž . mm, ACNrTHFrNaOAc 0.01 M, pH s 5 , 28:6:65; 1.5
showed a radiochemical purity ) 99%. . ml was added. The mixture was vigorously shaken at 378C for 30 min. One hundred microliters of the n-octanol layer and of the water layer were counted in a calibrated gamma counter. The partition coefficient was calculated Ž . using: log P s log counts in octanolrcounts in water .
Distribution studies in rat brain
Biodistribution
All experiments were carried out in compliance with the Law on Animal Experimentation of the Netherlands. Male Ž . Ž Wistar rats 229 " 22 g supplied by Harlan Lelystad, The . Netherlands were anesthetized by intraperitoneal injection Ž . of sodium pentobarbital 60 mgrkg . Two minutes before w 18 x Ž administration of F MPPF 2 MBq, S.A.) 110 . Ž TBqrmmol , the rats were treated either with saline con-. trol group or with the 5-HT receptor antagonist NAN-1A Ž . 190 2.5 mgrkg by i.v. injection into the tail vein. One hour after injection of the radioligand, the animals were sacrificed and 13 areas of the brain were dissected. The time course of the experiment is illustrated in Scheme 2. Tissue radioactivity was measured with a calibrated gamma counter. The samples were weighed and tissue uptake was expressed as standard uptake value Ž . Ž . Ž suv : cpm measuredrg tissue r cpm injectedrg body . weight . Residual uptake in the presence of NAN-190 was Ž considered to represent nonspecific binding Glennon et . al., 1988; Rydelek-Fitzgerald et al., 1990 . To modulate P-glycoprotein function in control and 5-HT blocked 1A Ž . animals, cyclosporin A 50 mgrkg was injected into the penile vein 30 min prior to radioligand administration Ž . Scheme 2 .
Dissection of brain regions
The entorhinal cortex and the piriform cortex containing the amygdaloid nucleus were removed on the ventral side of the brain. Olfactory bulbs were dissected and the brain was cut in three coronal slices. The first coronal cut was Ž . made "2 mm caudal to the olfactory bulbs A3000 mm , Ž . the second just caudal to the optic chiasm P1500 mm Ž . Doze et al., 1998; Palkovits and Brownstein, 1988 . From the first slice, anterior cingulaterfrontopolar cortex was dissected. The second slice was used to isolate striatum and frontal cortex. Thalami could be scooped out from the third brain slice. In the same slice, the remainder of the cortex was peeled off, containing parietal, temporal and occipital areas, after which the hippocampi could be removed as well. Then, the cerebellar hemispheres were removed from the hindbrain and the pons and medulla were obtained by sectioning through the pons just caudal to the occipital cortex. Right and left samples of all brain regions were pooled.
Phosphor screen imaging
Ž Male Wistar rats were either treated with saline con-. trols , the selective 5-HT receptor antagonist 1A or the selective 5-HT agonist 8-OH-DPAT, 2 min before 1A w 18 x injection of 10-15 MBq of F MPPF into the tail vein. After 60 min, the animals were sacrificed. Brains were removed from the skull, frozen on dry ice, and cut into . 1998 . Three slices were taken from the cerebellumr medulla. All slices were covered with a multi-purpose Ž . storage phosphor screen. After 20-24 h ) 10 half-lives of exposure, the screens were scanned using a storage phosphor system.
[
] 2.2.4. Plasma clearance of F MPPF
One of the carotid arteries of anesthetized male Wistar Ž . rats either untreated or treated with Cyclosporin A was cannulated. After radioligand administration, blood sam-Ž . ples 150 ml were drawn at different time intervals over a Ž period of 60 min. After centrifugation Hettich mikroliter;
. 3 min at 15.000 rpm , plasma radioactivity was measured with a calibrated gamma counter. The samples were weighed and plasma uptake was expressed as standard Ž . uptake value. The area under the curve AUC was calculated by nonlinear curve fitting. w 18 x administration of F MPPF into the tail vein, the animals were sacrificed and several tissues were dissected according to the procedure mentioned above. Tissue uptake of radioactivity was expressed as standard uptake value.
Results
[
] 3.1. F MPPF uptake and distribution in rat brain
Ž . We measured a log P of 2.14 " 0.06 n s 5 for w 18 x F MPPF. On the basis of this value, a good uptake of the radioligand in the brain could be expected. However, measured uptake values in biodistribution experiments were w 18 x quite low. The uptake of F MPPF in the brain of salineand NAN-190 pretreated Wistar rats is presented in Fig. 1 . Standard uptake values were in the range of 0.05-0.25. A Ž . significant reduction caused by NAN-190 2.5 mgrkg was observed in hippocampus, amygdalarpiriform-, cingu-Ž laterfrontopolar-, and entorhinal cortex Student's t-test, . n s 6: P -0.05 .
Because of the low standard uptake values, ex vivo phosphor storage imaging experiments were performed to w 18 x confirm the in vivo selectivity of F MPPF for the 5-HT 1A receptor in rat brain. The results for saline-and NAN-190 pretreated rats are displayed in Fig. 2 . Uptake was highest Ž . in septal and hippocampal areas Fig. 2A ; n s 3 . After Ž . treatment with NAN-190 2.5 mgrkg; n s 3 , specific Ž . binding was no longer observed Fig. 2B . w 18 x Tissuercerebellum ratios for F MPPF in the phosphor storage imaging experiments were excellently correlated with receptor densities measured by in vitro w autoradiography in the same animal species using metho-3 x Ž .Ž .x xy-H WAY 100635 Fig. 3 Khawaja, 1995 . w 18 x Ž . Ž . Fig. 4 . Central uptake of F MPPF 60 min p.i. after pretreatment with cyclosporin A 50 mgrkg 30 min prior to injection of the radioligand. Specific binding and regions are defined as in Fig. 1 . 
Influence of P-glycoprotein modulation on central [ 18 ] uptake and distribution of F MPPF in rats
After modulation of P-glycoprotein functionality by Ž pretreatment of animals with cyclosporin A 50 mgrkg, 30
. min prior to administration of F MPPF , tissue uptake Ž was increased in all brain regions Fig. 4 , compare Fig. 4 . with Fig. 1 ; P -0.05 . A significant reduction of tissue Ž . radioactivity by NAN-190 2.5 mgrkg could be seen in hippocampus, amygdalarpiriform-, cingulaterfrontopolar-, Ž .
) Ž . Fig. 6 . Difference in cerebral uptake between FVB wild and mdr1a yry knockout mice. Indicates significant difference Student's t-test, P -0.05 . Because the levels of radioactivity in plasma were increased after 60 min in the cyclosporin A-treated animals, the effect of cyclosporin A on ligand delivery to the brain was determined. The clearance rate of injected radioactivity was determined by analyzing the AUC for control and cyclosporin A-treated animals. A significant decrease in the clearance of MPPF-derived radioactivity was observed after treatment with cyclosporin A, leading Ž to a 1.84 " 0.37-fold increase of the AUC n s 5 for . control, n s 5 for cyclosporin A-treated animals . To confirm that the increased uptake of F MPPF in rat brain after pretreatment with cyclosporin A is due to modulation of P-glycoprotein functionality, biodistribution Ž . Ž . was compared in FVB-wild n s 5 and mdr1a yry Ž . w 18 x knockout mice n s 3 . Uptake of F MPPF in the brain Ž . of mdr1a yry knockout mice was two-to three-fold Ž . higher than in the wild type Fig. 6 . 
Discussion
Biodistribution experiments showed a five-to seven-fold lower brain uptake for the 5-HT receptor antagonist 1A MPPF compared to the prototype ligand WAY 100635 Ž .Ž Fig. 1A Plenevaux et al., 1997; Shiue et al., 1997; Pike . et al., 1994 . This was unexpected since the lipophilicity of MPPF is sufficient for rapid diffusion through the blood-Ž . brain barrier log P s 2.14 . Since biodistribution is a rather crude method that does not provide information on ligand Ž . uptake in small greater than a few millimeter areas, ex vivo autoradiography was performed using a phosphor Ž . storage system Fig. 2 . A laminar distribution of radioactivity was observed, which corresponds to 5-HT receptor 1A Ž . distribution in rat brain Fig. 2A . Tissuercerebellum ratios obtained from these images closely correlated with known receptor densities as determined by in vitro auto-Ž . Ž . radiography Fig. 3 Fig. 2B , confirming that F MPPF binds selectively to 5-HT receptors in rat brain in vivo.
1A
To determine the cause of the reduced cerebral uptake of MPPF as compared to WAY 100635, we decided to test if the former is a substrate for P-glycoprotein. After treatw 18 x ment with cyclosporin A, brain uptake of F MPPF was Ž . increased four-to six-fold Figs. 1 and 4 . Whereas in control rats, no significant specific binding could be observed in the frontal-, parietal-, temporal-, and occipital Ž . cortices in the biodistribution experiments Fig. 1 , modulation of P-glycoprotein functionality with cyclosporin A led to a significant difference between control and NAN-Ž . 190-pretreated animals in these regions Fig. 4 , while tissuercerebellum ratios remained in good agreement with w 3 x receptor densities as determined with methoxy-H WAY Ž . Ž . 100635 Fig. 5 Hume et al., 1994 . It is clear that in some brain areas, P-glycoprotein modulation results in increased radioligand uptake and, therefore, improved counting statistics.
w 18 x The increase of F MPPF derived radioactivity in the brain after administration of cyclosporin A was partially Ž due to increased ligand delivery to the brain AUC in . plasma: cyclosporin Arcontrols 1.84 . To prove that w 18 x F MPPF is a substrate for P-glycoprotein and that the observed differences in cerebral uptake between cyclosporin A-treated and control animals were not solely due to altered pharmacokinetics, we compared the cerebral Ž . uptake in wild type and mdr1a yry knockout mice. A Ž . significant increase two-to three-fold was found in the Ž . knockout mice Fig. 6 . These results lead us to conclude that the extra aromatic ring in MPPF causes an increased efflux action exerted by P-glycoprotein, and a lower brain uptake than would be predicted from its lipophilicity. The excellent results obtained with volunteers and with ex vivo storage phosphor imaging of rat brain show that the interaction with P-glycoprotein is not associated with a diminw 18 x ished selectivity of F MPPF for the 5-HT receptor 1A Ž . Passchier et al., 2000a,b , but it does stress the importance of taking the presence of P-glycoprotein into account during the development of radioligands for CNS receptors and for 5-HT receptor antagonists in particular. 
